150 related articles for article (PubMed ID: 35799272)
1. Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations.
von Dadelszen P; Audibert F; Bujold E; Bone JN; Sandhu A; Li J; Kariya C; Chung Y; Lee T; Au K; Skoll MA; Vidler M; Magee LA; Piedboeuf B; Baker PN; Lalji S; Lim KI
BMC Res Notes; 2022 Jul; 15(1):244. PubMed ID: 35799272
[TBL] [Abstract][Full Text] [Related]
2. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial.
Khalil A; Sharp A; Cornforth C; Jackson R; Mousa H; Stock S; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Von Dadelszen P; Magee L; Papageorghiou AT; Alfirevic Z
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):198-209. PubMed ID: 31432556
[TBL] [Abstract][Full Text] [Related]
3. STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.
Pels A; Kenny LC; Alfirevic Z; Baker PN; von Dadelszen P; Gluud C; Kariya CT; Mol BW; Papageorghiou AT; van Wassenaer-Leemhuis AG; Ganzevoort W; Groom KM;
BMC Pregnancy Childbirth; 2017 Dec; 17(1):440. PubMed ID: 29282009
[TBL] [Abstract][Full Text] [Related]
4. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial.
Sharp A; Cornforth C; Jackson R; Harrold J; Turner MA; Kenny LC; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z;
Lancet Child Adolesc Health; 2018 Feb; 2(2):93-102. PubMed ID: 30169244
[TBL] [Abstract][Full Text] [Related]
5. Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial.
Pels A; Derks J; Elvan-Taspinar A; van Drongelen J; de Boer M; Duvekot H; van Laar J; van Eyck J; Al-Nasiry S; Sueters M; Post M; Onland W; van Wassenaer-Leemhuis A; Naaktgeboren C; Jakobsen JC; Gluud C; Duijnhoven RG; Lely T; Gordijn S; Ganzevoort W;
JAMA Netw Open; 2020 Jun; 3(6):e205323. PubMed ID: 32585017
[TBL] [Abstract][Full Text] [Related]
6. STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
Groom KM; McCowan LM; Mackay LK; Lee AC; Gardener G; Unterscheider J; Sekar R; Dickinson JE; Muller P; Reid RA; Watson D; Welsh A; Marlow J; Walker SP; Hyett J; Morris J; Stone PR; Baker PN
BJOG; 2019 Jul; 126(8):997-1006. PubMed ID: 30779295
[TBL] [Abstract][Full Text] [Related]
7. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).
; Martins JG; Biggio JR; Abuhamad A
Am J Obstet Gynecol; 2020 Oct; 223(4):B2-B17. PubMed ID: 32407785
[TBL] [Abstract][Full Text] [Related]
8. Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction.
Pels A; Jakobsen JC; Ganzevoort W; Naaktgeboren CA; Onland W; van Wassenaer-Leemhuis AG; Gluud C
Trials; 2019 Jan; 20(1):42. PubMed ID: 30635020
[TBL] [Abstract][Full Text] [Related]
9. STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.
Ganzevoort W; Alfirevic Z; von Dadelszen P; Kenny L; Papageorghiou A; van Wassenaer-Leemhuis A; Gluud C; Mol BW; Baker PN
Syst Rev; 2014 Mar; 3():23. PubMed ID: 24618418
[TBL] [Abstract][Full Text] [Related]
10. Addition of sildenafil citrate for treatment of severe intrauterine growth restriction: a double blind randomized placebo controlled trial.
Shehata NAA; Ali HAA; Fahim AS; Katta MA; Hussein GK
J Matern Fetal Neonatal Med; 2020 May; 33(10):1631-1637. PubMed ID: 30345864
[No Abstract] [Full Text] [Related]
11. A prediction model for short-term neonatal outcomes in severe early-onset fetal growth restriction.
Sharp A; Jackson R; Cornforth C; Harrold J; Turner MA; Kenny L; Baker PN; Johnstone ED; Khalil A; von Dadelszen P; Papageorghiou AT; Alfirevic Z
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():109-118. PubMed ID: 31499415
[TBL] [Abstract][Full Text] [Related]
12. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
[TBL] [Abstract][Full Text] [Related]
13. Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate.
El-Sayed MA; Saleh SA; Maher MA; Khidre AM
J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1045-1050. PubMed ID: 28345432
[TBL] [Abstract][Full Text] [Related]
14. Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.
Liauw J; Groom K; Ganzevoort W; Gluud C; McKinlay CJD; Sharp A; Mackay L; Kariya C; Lim K; von Dadelszen P; Limpens J; Jakobsen JC;
Syst Rev; 2021 Dec; 10(1):305. PubMed ID: 34861900
[TBL] [Abstract][Full Text] [Related]
15. Maternal plasma soluble neuropilin-1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study.
Porter B; Maulik D; Babbar S; Schrufer-Poland T; Allsworth J; Ye SQ; Heruth DP; Lei T
Ultrasound Obstet Gynecol; 2021 Nov; 58(5):716-721. PubMed ID: 33533520
[TBL] [Abstract][Full Text] [Related]
16. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
[TBL] [Abstract][Full Text] [Related]
17. EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction.
Spencer R; Ambler G; Brodszki J; Diemert A; Figueras F; Gratacós E; Hansson SR; Hecher K; Huertas-Ceballos A; Marlow N; Marsál K; Morsing E; Peebles D; Rossi C; Sebire NJ; Timms JF; David AL;
BMC Pregnancy Childbirth; 2017 Jan; 17(1):43. PubMed ID: 28114884
[TBL] [Abstract][Full Text] [Related]
18. Use of sildenafil citrate in cases of intrauterine growth restriction (IUGR); a prospective trial.
Maged M; Wageh A; Shams M; Elmetwally A
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):483-486. PubMed ID: 30122565
[TBL] [Abstract][Full Text] [Related]
19. Infant outcome after active management of early-onset fetal growth restriction with absent or reversed umbilical artery blood flow.
Morsing E; Brodszki J; Thuring A; Maršál K
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):931-941. PubMed ID: 32862450
[TBL] [Abstract][Full Text] [Related]
20. Perinatal and Hemodynamic Evaluation of Sildenafil Citrate for Preeclampsia Treatment: A Randomized Controlled Trial.
Trapani A; Gonçalves LF; Trapani TF; Vieira S; Pires M; Pires MMS
Obstet Gynecol; 2016 Aug; 128(2):253-259. PubMed ID: 27400005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
